Polymorphisms and haplotypes in the multidrug resistance 1 gene (MDR1/ABCB1) and risk of multiple myeloma

被引:34
|
作者
Jamroziak, Krzysztof [1 ]
Balcerczak, Ewa [2 ]
Calka, Karolina [2 ]
Piaskowski, Sylwester [3 ]
Urbanska-Rys, Halina [1 ]
Salagacka, Aleksandra [2 ]
Mirowski, Marek [2 ]
Robak, Tadeusz [1 ]
机构
[1] Med Univ Lodz, Dept Hematol, PL-93513 Lodz, Poland
[2] Med Univ Lodz, Lab Mol Biol & Pharmacogenom, Dept Pharmaceut Biochem, Lodz, Poland
[3] Med Univ Lodz, Dept Mol Pathol & Neuropathol, Lodz, Poland
关键词
P-glycoprotein; MDR1; ABCB1; SNP; Haplotype; Multiple myeloma; Genetic predisposition; MDR1; GENE; SUSCEPTIBILITY;
D O I
10.1016/j.leukres.2008.06.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MDR1(ABCB1) gene encodes Cor P-glycoprotein (P-gp, MDR1, ABCB1), an ATP-binding cassette superfamily member involved in the transport of xenobiotics. Here, we investigated whether common MDR1 single nucleotide polymorphisms (1236C>T, 2677G>A/T and 3435C>T) affect predisposition to multiple myeloma. Genotyping was performed in 111 myeloma patients and 96 controls by PCR-based assays. Haplotypes were inferred Using PHASE algorithm. We found comparable allele and genotype frequencies among myeloma patients and controls. Moreover, patient and control groups did not differ regarding MDR1 haplotype distribution (p = 0.18). In conclusion, our results do not support major influence of MDR1 variants oil the risk of myeloma in Caucasians. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:332 / 335
页数:4
相关论文
共 50 条
  • [1] Functional implications of genetic polymorphisms in the multidrug resistance gene MDR1 (ABCB1)
    Pauli-Magnus, C
    Kroetz, DL
    PHARMACEUTICAL RESEARCH, 2004, 21 (06) : 904 - 913
  • [2] Functional Implications of Genetic Polymorphisms in the Multidrug Resistance Gene MDR1 (ABCB1)
    Christiane Pauli-Magnus
    Deanna L. Kroetz
    Pharmaceutical Research, 2004, 21 : 904 - 913
  • [3] MDR1/ABCB1 polymorphisms and multidrug resistance in epilepsy: in and out of fashion
    Loescher, Wolfgang
    Delanty, Norman
    PHARMACOGENOMICS, 2009, 10 (05) : 711 - 713
  • [4] Mechanism of multidrug recognition by MDR1/ABCB1
    Kimura, Yasuhisa
    Morita, Shin-ya
    Matsuo, Michinori
    Ueda, Kazumitsu
    CANCER SCIENCE, 2007, 98 (09): : 1303 - 1310
  • [5] ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer
    Balcerczak, Ewa
    Panczyk, Mariusz
    Piaskowski, Sylwester
    Pasz-Walczak, Grazyna
    Salagacka, Aleksandra
    Mirowski, Marek
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2010, 25 (10) : 1167 - 1176
  • [6] ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer
    Ewa Balcerczak
    Mariusz Panczyk
    Sylwester Piaskowski
    Grażyna Pasz-Walczak
    Aleksandra Sałagacka
    Marek Mirowski
    International Journal of Colorectal Disease, 2010, 25 : 1167 - 1176
  • [7] Relationship between genetic polymorphisms of multidrug resistance gene MDR1 (ABCB1) and clearance of 99mTc-MIBI
    Kapulu-Akca, C.
    Goktas, M.
    Babaoglu, M. O.
    Altundag, K.
    Yasar, U.
    Celik, I.
    Bozkurt, A.
    Erbas, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S304 - S304
  • [8] MDR1/ABCB1 gene polymorphisms in patients with chronic myeloid leukemia
    Lardo, Mabel
    Castro, Marcelo
    Moiraghi, Beatriz
    Rojas, Francisca
    Borda, Natalia
    Rey, Jorge A.
    Lazarowski, Alberto
    BLOOD RESEARCH, 2015, 50 (03) : 154 - 159
  • [9] MDRView: a visualization of the polymorphisms of MDR1(ABCB1) GENE in breast cancer
    Xhemo, Edlira
    Fajac, Anne
    Boire, Jean-Yves
    Levy, Pierre P.
    2007 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-16, 2007, : 4592 - +
  • [10] Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene
    Kroetz, DL
    Pauli-Magnus, C
    Hodges, LM
    Huang, CC
    Kawamoto, M
    Johns, SJ
    Stryke, D
    Ferrin, TE
    DeYoung, J
    Taylor, T
    Carlson, EJ
    Herskowitz, I
    Giacomini, KM
    Clark, AG
    PHARMACOGENETICS, 2003, 13 (08): : 481 - 494